These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16227547)

  • 1. How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales.
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1539-43. PubMed ID: 16227547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales.
    Riazi A; Hobart JC; Lamping DL; Fitzpatrick R; Thompson AJ
    Mult Scler; 2003 Aug; 9(4):411-9. PubMed ID: 12926848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Health Technol Assess; 2004 Mar; 8(9):iii, 1-48. PubMed ID: 14982653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study.
    Giordano A; Pucci E; Naldi P; Mendozzi L; Milanese C; Tronci F; Leone M; Mascoli N; La Mantia L; Giuliani G; Solari A
    J Neurol Neurosurg Psychiatry; 2009 Sep; 80(9):1023-8. PubMed ID: 19443471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.
    Hobart J; Lamping D; Fitzpatrick R; Riazi A; Thompson A
    Brain; 2001 May; 124(Pt 5):962-73. PubMed ID: 11335698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
    Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure.
    McGuigan C; Hutchinson M
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):266-9. PubMed ID: 14742602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Neurology; 2003 Jan; 60(1):31-6. PubMed ID: 12525714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite.
    Costelloe L; O'Rourke K; McGuigan C; Walsh C; Tubridy N; Hutchinson M
    Mult Scler; 2008 Mar; 14(2):255-8. PubMed ID: 17942522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the Croatian version of the depression, anxiety, and stress scale-21 and multiple sclerosis impact scale-29 in multiple sclerosis patients.
    Rogić Vidaković M; Šimić N; Poljičanin A; Nikolić Ivanišević M; Ana J; Đogaš Z
    Mult Scler Relat Disord; 2021 May; 50():102850. PubMed ID: 33636617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of selected aspects of psychometry of the Polish version of the Multiple Sclerosis Impact Scale 29 (MSIS-29)].
    Jamroz-Wiśniewska A; Papuć E; Bartosik-Psujek H; Belniak E; Mitosek-Szewczyk K; Stelmasiak Z
    Neurol Neurochir Pol; 2007; 41(3):215-22. PubMed ID: 17629814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use.
    van der Linden FA; Kragt JJ; Klein M; van der Ploeg HM; Polman CH; Uitdehaag BM
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1677-81. PubMed ID: 16291893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.
    Riazi A; Hobart JC; Lamping DL; Fitzpatrick R; Thompson AJ
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):701-4. PubMed ID: 12438473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale.
    Ravnborg M; Blinkenberg M; Sellebjerg F; Ballegaard M; Larsen SH; Sørensen PS
    Mult Scler; 2005 Feb; 11(1):81-4. PubMed ID: 15732271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of patient-reported outcome measures in multiple sclerosis.
    Schäffler N; Schönberg P; Stephan J; Stellmann JP; Gold SM; Heesen C
    Acta Neurol Scand; 2013 Aug; 128(2):114-21. PubMed ID: 23398571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported questionnaires in MS rehabilitation: responsiveness and minimal important difference of the multiple sclerosis questionnaire for physiotherapists (MSQPT).
    van der Maas NA
    BMC Neurol; 2017 Mar; 17(1):50. PubMed ID: 28302081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scales.
    Sonder JM; Bosma LV; van der Linden FA; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2012 Feb; 18(2):196-201. PubMed ID: 21908479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis.
    Goodwin E; Green C; Spencer A
    Value Health; 2015 Dec; 18(8):1025-36. PubMed ID: 26686787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-efficacy predicts self-reported health status in multiple sclerosis.
    Riazi A; Thompson AJ; Hobart JC
    Mult Scler; 2004 Feb; 10(1):61-6. PubMed ID: 14760954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.